U.S. Markets closed

How BioMarin Pharmaceutical Performed in 4Q17 and 2017

Daniel Collins
How BioMarin Pharmaceutical Performed in 4Q17 and 2017

A Post-4Q17 Update on BioMarin PharmaceuticalsBioMarin Pharmaceutical’s revenue trends